Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000935836-25-000426
Filing Date
2025-06-16
Accepted
2025-06-16 18:10:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 24362
2 logo_ex991.htm EX-99.1 AGREEMENT 6264
  Complete submission text file 0000935836-25-000426.txt   32556
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Subject) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-90647 | Film No.: 251051341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 LETTERMAN DRIVE BLDG C, SUITE C3-350 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE BLDG C, SUITE C3-350 SAN FRANCISCO CA 94129 4158014660
Logos Global Management LP (Filed by) CIK: 0001792126 (see all company filings)

EIN.: 833997742 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D